RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
WuXi AppTec formed a JV with the Mayo Clinic to co-develop and deliver novel esoteric clinical diagnostic services in China and the world. Combining WuXi’s operational experience with Mayo Medical Lab’s clinical and lab expertise, the two groups expect the JV to quickly develop new tests. Each company will offer the tests in their own markets. The clinical testing business is a relatively new offshoot of WuXi’s CRO/CMO major operational focus.
Source: China Biotoday